Tesamorelin 20 Pen

PEPTIVA TESAMORELIN 20 PEN contains Tesamorelin, a synthetic 44-amino-acid analogue of growth-hormone-releasing hormone (GHRH 1-44) stabilised with an N-terminal trans-3-hexenoic acid group, supplied as a 20mg/3ml pre-filled research pen.

What it is. Tesamorelin is a GHRH receptor agonist. Unusually for a research peptide, a pharmaceutical form of tesamorelin has been through regulated clinical trials and holds approval in some jurisdictions for a specific indication — this product is not that medicine and carries no approval.

Evidence status. Research literature covers hypothalamic–pituitary signalling models and lipid-metabolism endpoints in clinical study populations. The phrase on the carton (growth hormone support) describes a research area, not an outcome for this product. Research use only — not for human or animal use.

• Synthetic GHRH(1-44) analogue with N-terminal trans-3-hexenoic acid stabilisation
• GHRH receptor agonist studied in hypothalamic–pituitary signalling models
• A separate pharmaceutical form has regulated trial data; this research material carries no approval
• Research use only — not for human or animal use

Store refrigerated at 2°C–8°C. Do not freeze. Protect from light. (As printed on the carton.)

• 1 x Pre-Filled Pen (20mg/3ml)
• 20 x 31G 5mm Needles
• 1 x Instruction Leaflet
• Verification Code Inside

Batch TES2607A01 · Expiry 05/2029. Scan the QR on the back of the carton or verify online. Certificates of Analysis available on request by email.

Supplied strictly as a research material for laboratory and in-vitro use only. Not for human or animal use. Not a medicine, supplement or cosmetic. No information on this page constitutes dosing, administration or therapeutic guidance.